CN112043681B - 一种拉考沙胺药物组合物及其药物制剂 - Google Patents
一种拉考沙胺药物组合物及其药物制剂 Download PDFInfo
- Publication number
- CN112043681B CN112043681B CN202010504126.8A CN202010504126A CN112043681B CN 112043681 B CN112043681 B CN 112043681B CN 202010504126 A CN202010504126 A CN 202010504126A CN 112043681 B CN112043681 B CN 112043681B
- Authority
- CN
- China
- Prior art keywords
- lacosamide
- sustained release
- pharmaceutically acceptable
- acceptable salt
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (15)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210082074.9A CN114404393B (zh) | 2019-06-06 | 2020-06-05 | 一种拉考沙胺药物组合物及其药物制剂 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2019104901758 | 2019-06-06 | ||
CN201910490175 | 2019-06-06 | ||
CN2019111894960 | 2019-11-28 | ||
CN201911189496 | 2019-11-28 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210082074.9A Division CN114404393B (zh) | 2019-06-06 | 2020-06-05 | 一种拉考沙胺药物组合物及其药物制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112043681A CN112043681A (zh) | 2020-12-08 |
CN112043681B true CN112043681B (zh) | 2022-04-12 |
Family
ID=73609344
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210082074.9A Active CN114404393B (zh) | 2019-06-06 | 2020-06-05 | 一种拉考沙胺药物组合物及其药物制剂 |
CN202080053128.8A Pending CN114173763A (zh) | 2019-06-06 | 2020-06-05 | 一种拉考沙胺药物组合物及其药物制剂 |
CN202010504126.8A Active CN112043681B (zh) | 2019-06-06 | 2020-06-05 | 一种拉考沙胺药物组合物及其药物制剂 |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210082074.9A Active CN114404393B (zh) | 2019-06-06 | 2020-06-05 | 一种拉考沙胺药物组合物及其药物制剂 |
CN202080053128.8A Pending CN114173763A (zh) | 2019-06-06 | 2020-06-05 | 一种拉考沙胺药物组合物及其药物制剂 |
Country Status (5)
Country | Link |
---|---|
US (2) | US11337943B2 (zh) |
EP (1) | EP3981390A4 (zh) |
CN (3) | CN114404393B (zh) |
CA (1) | CA3148705A1 (zh) |
WO (1) | WO2020244615A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114699368B (zh) * | 2022-04-12 | 2023-05-19 | 南京海纳医药科技股份有限公司 | 一种拉考沙胺口服溶液及其制备方法 |
CN114983973B (zh) * | 2022-05-31 | 2023-05-05 | 石家庄四药有限公司 | 一种乌拉地尔缓释胶囊及其制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2496220B1 (en) * | 2009-11-03 | 2019-10-16 | Lupin Limited | Modified release formulation of lacosamide |
WO2011101863A2 (en) * | 2010-02-19 | 2011-08-25 | Cadila Healthcare Limited | Extended release pharmaceutical compositions of lacosamide |
AU2011335415B2 (en) * | 2010-12-02 | 2016-05-19 | Ucb Pharma Gmbh | Once daily formulation of lacosamide |
CN102920663B (zh) * | 2011-08-08 | 2015-02-11 | 丽珠医药集团股份有限公司 | 一种泛昔洛韦缓释微丸、其制备方法及应用 |
CN102670544B (zh) * | 2012-06-05 | 2016-04-06 | 石家庄四药有限公司 | 一种拉科酰胺缓释片及其制备方法 |
CN102885796A (zh) * | 2012-07-30 | 2013-01-23 | 永光制药有限公司 | 一种治疗癫痫的拉科酰胺片剂及其制备方法 |
KR20160117596A (ko) * | 2014-02-07 | 2016-10-10 | 오스펙스 파마슈티칼스, 인코포레이티드 | 신규 제약 제제 |
WO2016131947A1 (en) * | 2015-02-20 | 2016-08-25 | Ucb Biopharma Sprl | Combination treatment |
CA3008170A1 (en) * | 2015-12-30 | 2017-07-06 | Adamas Pharmaceuticals, Inc. | Methods and compositions for the treatment of seizure-related disorders |
CN105534949A (zh) * | 2016-01-06 | 2016-05-04 | 北京修正创新药物研究院有限公司 | 一种盐酸度洛西汀的肠溶微丸制剂 |
CN106619531A (zh) * | 2016-10-02 | 2017-05-10 | 上海奥科达生物医药科技有限公司 | 一种稳定的口服缓释混悬剂的制备方法 |
KR102083241B1 (ko) * | 2018-02-14 | 2020-03-02 | 환인제약 주식회사 | 라코사미드를 함유하는 약제학적 서방성 조성물 |
-
2020
- 2020-06-05 CN CN202210082074.9A patent/CN114404393B/zh active Active
- 2020-06-05 EP EP20819422.5A patent/EP3981390A4/en active Pending
- 2020-06-05 CN CN202080053128.8A patent/CN114173763A/zh active Pending
- 2020-06-05 WO PCT/CN2020/094556 patent/WO2020244615A1/zh active Application Filing
- 2020-06-05 CN CN202010504126.8A patent/CN112043681B/zh active Active
- 2020-06-05 CA CA3148705A patent/CA3148705A1/en not_active Abandoned
-
2021
- 2021-02-17 US US17/177,485 patent/US11337943B2/en active Active
-
2022
- 2022-05-23 US US17/664,513 patent/US11883374B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN114404393B (zh) | 2023-02-24 |
EP3981390A1 (en) | 2022-04-13 |
CN114173763A (zh) | 2022-03-11 |
CN114404393A (zh) | 2022-04-29 |
US20210283076A1 (en) | 2021-09-16 |
CA3148705A1 (en) | 2020-12-10 |
EP3981390A4 (en) | 2023-01-25 |
US11337943B2 (en) | 2022-05-24 |
US20220280456A1 (en) | 2022-09-08 |
CN112043681A (zh) | 2020-12-08 |
WO2020244615A1 (zh) | 2020-12-10 |
US11883374B2 (en) | 2024-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2348090C (en) | Oral pulsed dose drug delivery system | |
US20220062204A1 (en) | Methods and compositions for the treatment of seizure-related disorders | |
AU2004289223B2 (en) | Once daily dosage forms of trospium | |
US20110189269A1 (en) | Extended release composition containing tramadol | |
PL200816B1 (pl) | Powleczony rdzeń o opóźnionym uwalnianiu dający impuls czasowy uwalniania i farmaceutyczna postać dawkowana | |
CZ303495B6 (cs) | Mnohocásticový modifikovane uvolnující prostredek a jeho použití, pevná orální dávkovací forma | |
CZ296964B6 (cs) | Farmaceutické formulace tramadolu v násobných jednotkách a zpusob jejich výroby | |
US20020031550A1 (en) | Controlled release dosage form of [R-(Z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2]oct-3yl) acetonitrile monohydrochloride | |
CN112043681B (zh) | 一种拉考沙胺药物组合物及其药物制剂 | |
MXPA06008854A (es) | Mini tabletas de clorhidrato de venlafaxina de liberacion prolongada recubiertas. | |
US20070092568A1 (en) | Galantamine compositions | |
CA2984235C (en) | Rivastigmine-containing sustained-release pharmaceutical composition | |
US20240041803A1 (en) | Lacosamide pharmaceutical composition and dosage form thereof | |
EP2736496B1 (en) | Pharmaceutical composition containing an antimuscarinic agent and method for the preparation thereof | |
WO2011027322A1 (en) | Extended release dosage form containing olopatadine for oral administration | |
CN117425471A (zh) | 包含托莫西汀的延长释放组合物 | |
NZ743322A (en) | Methods and compositions for the treatment of seizure-related disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Lv Shaoqiong Inventor after: Li Shoufeng Inventor after: Zheng Xun Inventor after: Wang Zhongqin Inventor before: Lv Shaoqiong Inventor before: Li Shoufeng Inventor before: Ma Hongyan Inventor before: Zheng Xun Inventor before: Wang Zhongqin |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: No.10, Lane 100, Banxia Road, Pudong New Area, Shanghai, 201318 Patentee after: Shanghai Aokeda Pharmaceutical Technology Co.,Ltd. Address before: No.10, Lane 100, Banxia Road, Pudong New Area, Shanghai, 201318 Patentee before: SHANGHAI AUCTA PHARMACEUTICALS Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |